Company Filing History:
Years Active: 2020-2024
Title: Tsung-Jui Lin: Pioneer in Biomedical Innovations
Introduction
Tsung-Jui Lin, an accomplished inventor hailing from Hsinchu, Taiwan, has made significant contributions to the field of biomedical innovations. With a total of eight patents to his name, he focuses on developing advanced devices that enhance the efficiency of medical diagnostics.
Latest Patents
Among his noteworthy inventions is the "Package structure having packaged light detecting components within and package method thereof." This innovative package structure utilizes a circuit board with multiple light detecting components that are protected by a light-transmittable sealing cap. By incorporating light filtering films, each detecting component can target different frequency bands of light, all while simplifying the manufacturing process and reducing costs.
Another significant invention is the "Sanitary device for urine glucose test." This device features a urine container with an integrated measuring module that analyzes urine samples for glucose levels. It utilizes a lens and a driving module to shoot detection beams onto a measuring surface. The results are processed instantly, offering efficient and accurate glucose level readings.
Career Highlights
Tsung-Jui Lin is currently associated with Taiwan Redeye Biomedical Inc., where he applies his expertise in creating innovative biomedical devices. His work significantly contributes to improving diagnostic techniques and health monitoring solutions.
Collaborations
Throughout his career, Tsung-Jui Lin has collaborated with talented individuals such as Shuo-Ting Yan and Yu-Hsun Chen. These collaborations have fostered a creative environment that enhances the innovation process within biomedical research and development.
Conclusion
Tsung-Jui Lin exemplifies the spirit of innovation in the biomedical field. His patents not only showcase his technical prowess but also contribute profoundly to advancements in medical diagnostics. The impact of his work is expected to resonate within the industry and improve healthcare outcomes globally.